BioNTech Target of Unusually High Options Trading …

Jan 8, 2025 · BioNTech SE (NASDAQ:BNTX – Get Free Report) was the target of some unusual options trading on Tuesday. Stock traders acquired 4,599 call options on the company. This …

$95.00
OFF

BioNTech Sees Unusually Large Options Volume (NASDAQ:BNTX)

2 weeks from now

Jan 7, 2025 · Deutsche Bank Aktiengesellschaft increased their price target on BioNTech from $95.00 to $150.00 and gave the company a "buy" rating in a research note on Thursday, …

marketbeat.com

$97.00
OFF

BioNTech (NASDAQ:BNTX) Sees Strong Trading Volume

2 weeks from now

Jan 7, 2025 · UBS Group raised their price target on BioNTech from $97.00 to $131.00 and gave the company a "neutral" rating in a report on Wednesday, September 18th. Canaccord …

marketbeat.com

$378
OFF

Analyzing BioNTech's Unusual Options Activity - Benzinga

2 weeks from now

Aug 11, 2021 · Shares of BioNTech (NASDAQ:BNTX) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved down to $378.

benzinga.com

$109.54
OFF

Analyzing BioNTech's Unusual Options Activity - Yahoo Finance

2 weeks from now

Mar 1, 2021 · Shares of BioNTech (NASDAQ: BNTX) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $109.54. Sentiment: …

yahoo.com

$75.00
OFF

Implied Volatility Surging For BioNTech (BNTX) Stock Options

2 weeks from now

Feb 3, 2023 · Investors in BioNTech SE BNTX need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 17, 2023 $75.00 Call had some of …

yahoo.com

$324.98
OFF

Understanding BioNTech's Unusual Options Activity - Webull

2 weeks from now

On Friday, shares of BioNTech (NASDAQ:BNTX) saw unusual options activity. After the option alert, the stock price moved up to $324.98. Sentiment: BULLISH; Option Type: SWEEP; ...

webull.com

$126.94
OFF

Breaking Down BioNTech: 16 Analysts Share Their Views

2 weeks from now

Nov 6, 2024 · Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $126.94, with a high estimate of $150.00 and a low estimate of $91.00.

nasdaq.com

$102.38
OFF

Forecasting The Future: 8 Analyst Projections For BioNTech

2 weeks from now

Sep 13, 2024 · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $102.38, a high estimate of $113.00, and a low …

nasdaq.com

$110
OFF

This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For ...

2 weeks from now

Nov 19, 2024 · Evercore ISI Group analyst Cory Kasimov upgraded the rating for BioNTech SE BNTX from In-Line to Outperform and boosted the price target from $110 to $125. BioNTech …

benzinga.com

$140.76
OFF

BioNTech (BNTX) Stock Forecast And Price Target 2025 - MarketBeat

2 weeks from now

6 days ago · BioNTech SE has received multiple upgrades from analysts, with a current average price target of $140.76, suggesting that analysts are optimistic about the company's future …

marketbeat.com

$150
OFF

BofA Maintains Buy On BioNTech, Price Target At $150

2 weeks from now

Nov 4, 2024 · BofA maintains Buy on BioNTech, price target at $150. Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing …

investing.com

FAQs about BioNTech Target of Unusually High Options Trading … Coupon?

Are options traders pricing in a big move for biontech shares?

Clearly, options traders are pricing in a big move for BioNTech shares, but what is the fundamental picture for the company? Currently, BioNTech is a Zacks Rank #5 (Strong Sell) in the Medical - Biomedical and Genetics industry that ranks in the Top 45% of our Zacks Industry Rank. ...

Should you buy BioNTech stock?

BioNTech has a market capitalization of $11 billion, which is half of Moderna's. However, the main reason to consider buying BioNTech stock is its long-term potential in its oncology pipeline and drug-discovery capabilities. Keep in mind that the company will need to raise additional capital in the coming months, which could potentially cause a dip in the stock price. ...

What is the average price target for biontech (bntx)?

According to the 14 analysts' twelve-month price targets for BioNTech, the average price target is $135.54. The highest price target for BNTX is $171.00, while the lowest price target for BNTX is $100.00. The average price target represents a forecasted upside of 22.24% from the current price of $110.88. ...

Who owns biontech stock?

Daiwa Securities Group Inc. now owns 1,925 shares of the company’s stock worth $155,000 after acquiring an additional 1,562 shares during the last quarter. Finally, Caprock Group LLC bought a new stake in BioNTech during the second quarter valued at about $206,000. 15.52% of the stock is owned by institutional investors. ...

Will biontech SE meet market expectations?

BioNTech SE's recent earnings per share (EPS) results have fallen short of consensus estimates, raising concerns about its ability to meet market expectations. The company's revenue for the quarter was down 23.3% year-over-year, reflecting a decline in sales that may affect future profitability and investor confidence. ...

Is biontech a good buy in the medical - biomedical and genetics industry?

Currently, BioNTech is a Zacks Rank #5 (Strong Sell) in the Medical - Biomedical and Genetics industry that ranks in the Top 45% of our Zacks Industry Rank. Over the last 30 days, no analysts have increased their earnings estimates for the current quarter, while two analysts have revised their estimates downward. ...